TRT vs. PEDs: what the 'big difference' claim actually holds up to

What did @coachedbyzane actually say?

The creator drew a line between TRT and a testosterone cycle based on dosage and blood levels. His argument: TRT keeps you in the "high normal range," and the dose varies by person, anywhere from 150 mg to 250 mg per week. A cycle, by contrast, pushes you into "super physiological" territory, starting around 300 to 350 mg per week and up. He ended with a jab at people who ask about his "T-Sha take" without understanding the basic distinction.

The framing is simple and conversational, which works for TikTok. But simple framings can cut corners, and this one does in a few places worth examining closely.

Does the science back this up?

Partially, yes. The conceptual split between replacement and supraphysiological dosing is real and clinically meaningful. But the dose ranges he cites for TRT are significantly higher than what most clinical guidelines actually endorse.

The American Urological Association and the Endocrine Society define hypogonadism treatment as restoring total testosterone to within the normal reference range, roughly 300 to 1000 ng/dL depending on the lab. Standard clinical doses of testosterone cypionate or enanthate for diagnosed hypogonadism typically run between 50 mg and 200 mg per week, with most patients landing in the 100 to 150 mg range (Bhasin et al., 2010, Journal of Clinical Endocrinology and Metabolism). His upper TRT boundary of 250 mg per week is where the clinical evidence gets thin and the "optimization" framing takes over from the medical one.

On the cycle side, the supraphysiological threshold is well-documented. Bhasin's landmark 1996 NEJM study used 600 mg per week to demonstrate muscle gains beyond normal physiology. His 300 to 350 mg floor is a reasonable estimate of where supraphysiological effects begin for most men.

What did they get wrong (or right)?

Credit where it is due: the core distinction is correct. There is a meaningful biological difference between restoring testosterone to a normal range and flooding your system with doses that exceed normal human physiology. That distinction matters for risk, and the creator is right to make it.

What he got wrong, or at least blurred, is the upper end of his TRT range. Saying some people "might need 250" mg per week to hit the high normal range is not well-supported by clinical literature. At 250 mg per week, most men with average metabolism will not land in the normal range. They will overshoot it considerably. A 2021 review by Ramasamy et al. in Translational Andrology and Urology found that individualized dosing in clinical TRT rarely exceeds 200 mg weekly for maintenance of normal-range levels.

Calling 250 mg per week TRT is a label choice with real consequences. It normalizes doses that many endocrinologists would classify as low-dose cycling, not replacement. This is not a trivial semantic point.

What should you actually know?

If you are considering TRT for diagnosed hypogonadism, your dose should be determined by blood work, not a TikTok benchmark. The goal of replacement therapy is to restore levels, not to maximize them. "High normal" is not a target most physicians agree on as a universal standard.

The distinction between TRT and cycling also matters legally and medically. TRT for diagnosed hypogonadism is a legitimate medical treatment. Self-directed supraphysiological dosing is a different category entirely, carrying risks including erythrocytosis, cardiovascular strain, testicular atrophy, and lipid disruption (Corona et al., 2017, Expert Opinion on Drug Safety).

The creator is talking to an audience that overlaps significantly with people who are either already using performance-enhancing drugs or considering them. Framing 250 mg per week as potentially qualifying as TRT softens a line that, from a clinical standpoint, should stay relatively firm. Know where that line actually is before you decide which side of it you are on.